Merck did not issue a release or note the FDA’s reasoning behind the rejection, but included a brief mention in the company’s regulatory filing with the Securities and Exchange Commission, the report said,
Related Articles on Ophthalmology:
Study: Patients With Glaucoma Vision Loss Have Higher Fall Risk
Ophthalmologist on the Move: Dr. Rodney P. Coe Joins the Retina Group of New York
10 Points on Ophthalmology in Surgery Centers
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.